Skip to main content
Clemens Scherzer, MD, Neurology, Boston, MA, Brigham and Women's Hospital

ClemensRudolfScherzerMD

Neurology Boston, MA

Movement Disorder

Professor of Neurology, Harvard Medical School | Director, BWH Precision Neurology Program | Center Director, APDA Center for Advanced Parkinson Disease Research | Co-Founder and Co-Director, Harvard Biomarkers Study

Dr. Scherzer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Scherzer's full profile

Already have an account?

Summary

  • Solve Parkinson's disease with precision neurology

    www.scherzerlaboratory.org

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineResidency, Neurology, 1998 - 2001
  • Emory University School of Medicine
    Emory University School of MedicineInternship, Transitional Year, 1997 - 1998
  • University of Vienna Faculty of Medicine
    University of Vienna Faculty of MedicineClass of 1995

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2003 - 2024
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Journal Articles

  • PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease  
    Zheng, B. Liao, Z. Locascio, J. J. Lesniak, K. A. Roderick, S. S. Watt, M. L. Eklund, A. C. Zhang-James, Y. Kim, P. D. Hauser, M. A. Grunblatt, E. Moran, L. B. Mandel,..., Science Translational Medicine, 2010

Press Mentions

  • Study Uncovers Genetic Variants Linked to Disease Progression
    Study Uncovers Genetic Variants Linked to Disease ProgressionMay 10th, 2021
  • Sensitive ELISA-Based Detection Method for the Mitophagy Marker P-s65-Ub in Human Cells, Autopsy Brain, and Blood Samples
    Sensitive ELISA-Based Detection Method for the Mitophagy Marker P-s65-Ub in Human Cells, Autopsy Brain, and Blood SamplesMarch 13th, 2020
  • In Small Study, Parkinson's Disease Patients with LRRK2 Mutation Have Elevated Risk for Different Cancers
    In Small Study, Parkinson's Disease Patients with LRRK2 Mutation Have Elevated Risk for Different CancersSeptember 19th, 2019
  • Join now to see all

Grant Support

  • Risk Marker For Parkinson'S Disease: Enabling Novel TherapiesNational Institute Of Neurological Disorders And Stroke2008–2011
  • Genomic Markers Of Disease Progression In Huntington'S DiseaseNational Institute Of Neurological Disorders And Stroke2008
  • Multigene Marker Of Progression In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2007–2008
  • Genomic And Genetic Analysis Of Parkinson'S DiseaseNational Institute On Aging2004–2008

Professional Memberships

Hospital Affiliations